Literature DB >> 32317775

Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma.

Hans C Lee1, Noopur S Raje2, Ola Landgren3, Vijay V Upreti4, Jin Wang5, Ariel A Avilion6, Xuguang Hu6, Erik Rasmussen7, Gataree Ngarmchamnanrith8, Hisaki Fujii9, Andrew Spencer10.   

Abstract

Entities:  

Year:  2020        PMID： 32317775     DOI： 10.1038/s41375-020-0834-9

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.

Authors:  Niels W C J van de Donk; Maria Themeli; Saad Z Usmani
Journal:  Blood Cancer Discov       Date:  2021-07

2.  Diagnosed with myeloma before age 40.

Authors:  Ola Landgren; Dickran Kazandjian
Journal:  Blood       Date:  2021-12-23       Impact factor: 22.113

Review 3.  Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.

Authors:  Alessandra Romano; Paola Storti; Valentina Marchica; Grazia Scandura; Laura Notarfranchi; Luisa Craviotto; Francesco Di Raimondo; Nicola Giuliani
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

Review 4.  Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf.

Authors:  Gregorio Barilà; Rita Rizzi; Renato Zambello; Pellegrino Musto
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-07

Review 5.  Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma.

Authors:  Waqqas Tai; Ahsan Wahab; Diana Franco; Zunairah Shah; Aqsa Ashraf; Qurrat-Ul-Ain Abid; Yaqub Nadeem Mohammed; Darshan Lal; Faiz Anwer
Journal:  Antibodies (Basel)       Date:  2022-03-24

Review 6.  Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon?

Authors:  Monique Hartley-Brown; Paul Richardson
Journal:  Explor Target Antitumor Ther       Date:  2022-01-14

Review 7.  Race for the Cure: From the Oldest to the Newest Monoclonal Antibodies for Multiple Myeloma Treatment.

Authors:  Gianfranco Lapietra; Francesca Fazio; Maria Teresa Petrucci
Journal:  Biomolecules       Date:  2022-08-19

Review 8.  Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma.

Authors:  Jakub Radocha; Niels W C J van de Donk; Katja Weisel
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

Review 9.  Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review.

Authors:  Hiroko Nishida
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

Review 10.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.